Prophylaxis and management of graft versus host disease after stem-cell transplantation for haematological malignancies: updated consensus recommendations of the European Society for Blood and Marrow Transplantation

Key updates in these guidelines include recommendations for lower steroid doses for the management of grade 2 acute GVHD with isolated skin or upper gastrointestinal tract manifestations and the addition of newer treatment options for steroid-refractory acute and chronic GVHD.

The Lancet Haematology